Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyond [PDF]
Human Vaccines & ImmunotherapeuticsWide use of the groundbreaking vaccine MenAfriVac® has eliminated serogroup A meningococcal meningitis in the African meningitis belt and paved the way for elimination of all meningococcal disease outbreaks with the development, licensure, and ...
Mark R. Alderson +7 more
doaj +2 more sources
Neisseria Meningitidis Causing Multiple Cerebral Abscesses in Early Neonatal Period: Case Report and Review of Literature [PDF]
Journal of Clinical and Diagnostic Research, 2017 Neisseria meningitidis is a rare cause of meningitis and septicemia in neonates. There are few published case reports of neonatal meningococcal meningitis complicated by subdural empyema, cerebral abscess and hydrocephalus.
LAXMAN BASANI, ROJA AEPALA
doaj +1 more source
Meningococcal vaccines in China
Human Vaccines & Immunotherapeutics, 2021 Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines.
Yinghua Xu +5 more
doaj +1 more source
Pediatric bacterial meningitis and meningococcal disease profile in a Brazilian General Hospital
Brazilian Journal of Infectious Diseases, 2020 Objective: To evaluate the clinical and epidemiological profile of bacterial meningitis and meningococcal disease in pediatric patients admitted to a Brazilian Secondary Public Hospital.
Bruna P. Blanco +3 more
doaj +1 more source
Neisseria meningitidis pneumonia with bacteremia without meningitis: An atypical presentation
IDCases, 2020 Neisseria meningitidis remains the most important cause of bacterial meningitis worldwide. The second most common and potentially severe end-organ manifestation of invasive meningococcal disease is meningococcal pneumonia.
Fatma Mohamed Mahmoud, Thana Harhara
doaj +1 more source
mSphere, 2018 Neisseria meningitidis is a common cause of bacterial meningitis in children and young adults worldwide. The 4CMenB vaccine (Bexsero), developed to combat meningococcal serogroup B (MenB) disease, contains subcapsular antigens that may induce immunity ...
Robert M. Mulhall +12 more
doaj +1 more source
Current status and challenges of meningococcal vaccines development in China
Zhongguo gonggong weisheng, 2022 Vaccination is the most effective and economical way to prevent meningococcal meningitis. In the past few decades, with widespread use of meningococcal vaccines, the incidence of meningococcal meningitis has dropped significantly. There are some vaccines
Ying-hua XU, Ya-nan LI, Qiang YE
doaj +1 more source
Meningitis epidemics shift in sub-Saharan belt
International Journal of Infectious Diseases, 2018 Meningococcal meningitis (MCM) poses a serious threat to public health in Africa. Epidemics appear irregularly every 5–12 years, especially in the regions across sub-Saharan ‘meningitis belt’. This study investigated the long-term spatiotemporal dynamics
Shi Zhao +3 more
doaj +1 more source
Acute myelopathy with sudden paraplegia as the sole manifestation of meningococcal meningitis
Libyan Journal of Medicine, 2010 Acute myelopathy with sudden paraplegia is a very rare manifestation of meningococcal meningitis, with only a few cases reported in the literature.
Wanis H. Ibrahim +4 more
doaj +1 more source
Comparing laboratory surveillance with the notifiable diseases surveillance system in South Africa
International Journal of Infectious Diseases, 2017 Objective: The aim of this study was to compare laboratory surveillance with the notifiable diseases surveillance system (NDSS) in South Africa. Methods: Data on three tracer notifiable diseases – measles, meningococcal meningitis, and typhoid – were ...
F.G. Benson +3 more
doaj +1 more source